GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioNeutra Global Corp (TSXV:BGA) » Definitions » Asset Impairment Charge

BioNeutra Global (TSXV:BGA) Asset Impairment Charge : C$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is BioNeutra Global Asset Impairment Charge?

BioNeutra Global's Asset Impairment Charge for the three months ended in Jun. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00 Mil.


BioNeutra Global Asset Impairment Charge Historical Data

The historical data trend for BioNeutra Global's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNeutra Global Asset Impairment Charge Chart

BioNeutra Global Annual Data
Trend Feb14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioNeutra Global Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioNeutra Global Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.


BioNeutra Global Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of BioNeutra Global's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNeutra Global Business Description

Traded in Other Exchanges
Address
9608 - 25 Avenue NW, Edmonton, AB, CAN, T6N 1J4
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Executives
Monica Barclay Senior Officer

BioNeutra Global Headlines

No Headlines